市場調査レポート：世界のクレアチンリン酸ナトリウムAPI市場（～2028年）：純度≥99%、純度

• 英文タイトル：Global Creatine Phosphate Sodium API Market Insights, Forecast to 2028

Global Creatine Phosphate Sodium API Market Insights, Forecast to 2028「世界のクレアチンリン酸ナトリウムAPI市場（～2028年）：純度≥99%、純度<99%」（市場規模、市場予測）調査レポートです。

• レポートコード：MRC2Q12-01469
• 出版社/出版日：QYResearch / 2022年12月
• レポート形態：英文、PDF、114ページ
• 納品方法：Eメール（納期：3営業日）
• 産業分類：化学&材料

• 販売価格（消費税別）

Single User	￥735,000 (USD4,900)	▷ お問い合わせ
Enterprise License	￥1,470,000 (USD9,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

レポート概要

新型コロナウイルス感染症とロシア・ウクライナ戦争の影響により、クレアチンリン酸ナトリウムAPIのグローバル市場は 2022にxxxドルと推定され、2028年までにxxxドルの規模に達し、2022年から2028年の予測期間中にxxx%のCAGRで成長すると予測されています。
クレアチンリン酸ナトリウムAPIのアメリカ市場は、2023年から2028年の予測期間中にxxx%のCAGRで、2022年xxxドルから2028年xxxドルに達すると推定されています。
クレアチンリン酸ナトリウムAPIの中国市場は、2023年から2028年の予測期間中にxxx%のCAGRで、2022年xxxドルから2028年xxxドルに達すると推定されています。
クレアチンリン酸ナトリウムAPIのヨーロッパ市場は、2023年から2028年の予測期間中にxxx%のCAGRで、2022年xxxドルから2028年xxxドルに達すると推定されています。

生産面において、本レポートは2017年から2022年までのクレアチンリン酸ナトリウムAPIの生産、成長率、メーカー別市場シェア、地域別市場シェア、および2028年までの予測を調査しています。販売面において、本レポートは2017年から2022年までの地域別、企業別、タイプ別、アプリケーション別のクレアチンリン酸ナトリウムAPIの売上および2028年までの予測に焦点を当てています。

クレアチンリン酸ナトリウムAPIのグローバル主要企業には、Luoxin Pharmaceutical、Harbin Laiboten Pharmaceutical、Haikou Qili Pharmaceutical、Jilin Yinglian Biopharmaceutical、Hebei Tiancheng Pharmaceutical、Chongqing Shenghuaxi Pharm、Amicogen China、Kaifeng Mingren Pharmaceuticals、Beijing Polay Pharmaceuticals、Hainan ChoiteC Pharmaceuticals、Qidong Huatuo Pharmaceuticalなどがあります。2021年、世界のトップ5プレイヤーは売上ベースで約xxx％の市場シェアを占めています。

クレアチンリン酸ナトリウムAPI市場は、タイプとアプリケーションによって区分されます。世界のクレアチンリン酸ナトリウムAPI市場のプレーヤー、利害関係者、およびその他の参加者は、当レポートを有益なリソースとして使用することで優位に立つことができます。セグメント分析は、2017年～2028年期間のタイプ別およびアプリケーション別の販売量、売上、予測に焦点を当てています。

【タイプ別セグメント】
純度≥99%、純度<99%

【アプリケーション別セグメント】
注射、経口固形製剤

【掲載地域】
北米：アメリカ、カナダ
ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア
アジア太平洋：日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア
中南米：メキシコ、ブラジル、アルゼンチン
中東・アフリカ：トルコ、サウジアラビア、UAE

【目次（一部）】

・調査の範囲
- クレアチンリン酸ナトリウムAPI製品概要
- タイプ別市場（純度≥99%、純度<99%）
- アプリケーション別市場（注射、経口固形製剤）
- 調査の目的
・エグゼクティブサマリー
- 世界のクレアチンリン酸ナトリウムAPI販売量予測2017-2028
- 世界のクレアチンリン酸ナトリウムAPI売上予測2017-2028
- クレアチンリン酸ナトリウムAPIの地域別販売量
- クレアチンリン酸ナトリウムAPIの地域別売上
- 北米市場
- ヨーロッパ市場
- アジア太平洋市場
- 中南米市場
- 中東・アフリカ市場
・メーカーの競争状況
- 主要メーカー別クレアチンリン酸ナトリウムAPI販売量
- 主要メーカー別クレアチンリン酸ナトリウムAPI売上
- 主要メーカー別クレアチンリン酸ナトリウムAPI価格
- 競争状況の分析
- 企業M&A動向
・タイプ別市場規模（純度≥99%、純度<99%）
- クレアチンリン酸ナトリウムAPIのタイプ別販売量
- クレアチンリン酸ナトリウムAPIのタイプ別売上
- クレアチンリン酸ナトリウムAPIのタイプ別価格
・アプリケーション別市場規模（注射、経口固形製剤）
- クレアチンリン酸ナトリウムAPIのアプリケーション別販売量
- クレアチンリン酸ナトリウムAPIのアプリケーション別売上
- クレアチンリン酸ナトリウムAPIのアプリケーション別価格
・北米市場
- 北米のクレアチンリン酸ナトリウムAPI市場規模（タイプ別、アプリケーション別）
- 主要国別のクレアチンリン酸ナトリウムAPI市場規模（アメリカ、カナダ）
・ヨーロッパ市場
- ヨーロッパのクレアチンリン酸ナトリウムAPI市場規模（タイプ別、アプリケーション別）
- 主要国別のクレアチンリン酸ナトリウムAPI市場規模（ドイツ、フランス、イギリス、イタリア、ロシア）
・アジア太平洋市場
- アジア太平洋のクレアチンリン酸ナトリウムAPI市場規模（タイプ別、アプリケーション別）
- 主要国別のクレアチンリン酸ナトリウムAPI市場規模（日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア）
・中南米市場
- 中南米のクレアチンリン酸ナトリウムAPI市場規模（タイプ別、アプリケーション別）
- 主要国別のクレアチンリン酸ナトリウムAPI市場規模（メキシコ、ブラジル、アルゼンチン）
・中東・アフリカ市場
- 中東・アフリカのクレアチンリン酸ナトリウムAPI市場規模（タイプ別、アプリケーション別）
- 主要国別のクレアチンリン酸ナトリウムAPI市場規模（トルコ、サウジアラビア）
・企業情報
Luoxin Pharmaceutical、Harbin Laiboten Pharmaceutical、Haikou Qili Pharmaceutical、Jilin Yinglian Biopharmaceutical、Hebei Tiancheng Pharmaceutical、Chongqing Shenghuaxi Pharm、Amicogen China、Kaifeng Mingren Pharmaceuticals、Beijing Polay Pharmaceuticals、Hainan ChoiteC Pharmaceuticals、Qidong Huatuo Pharmaceutical
・産業チェーン及び販売チャネル分析
- クレアチンリン酸ナトリウムAPIの産業チェーン分析
- クレアチンリン酸ナトリウムAPIの原材料
- クレアチンリン酸ナトリウムAPIの生産プロセス
- クレアチンリン酸ナトリウムAPIの販売及びマーケティング
- クレアチンリン酸ナトリウムAPIの主要顧客
・マーケットドライバー、機会、課題、リスク要因分析
- クレアチンリン酸ナトリウムAPIの産業動向
- クレアチンリン酸ナトリウムAPIのマーケットドライバー
- クレアチンリン酸ナトリウムAPIの課題
- クレアチンリン酸ナトリウムAPIの阻害要因
・主な調査結果

Market Analysis and Insights: Global Creatine Phosphate Sodium API Market
Due to the COVID-19 pandemic, the global Creatine Phosphate Sodium API market size is estimated to be worth US$ million in 2022 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the forecast period 2022-2028. Fully considering the economic change by this health crisis, Purity≥99% accounting for % of the Creatine Phosphate Sodium API global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR from 2022 to 2028. While Injection segment is altered to an % CAGR throughout this forecast period.
China Creatine Phosphate Sodium API market size is valued at US$ million in 2021, while the US and Europe Creatine Phosphate Sodium API are US$ million and US$ million, severally. The proportion of the US is % in 2021, while China and Europe are % and % respectively, and it is predicted that China proportion will reach % in 2028, trailing a CAGR of % through the analysis period 2022-2028. Japan, South Korea, and Southeast Asia are noteworthy markets in Asia, with CAGR %, %, and % respectively for the next 6-year period. As for the Europe Creatine Phosphate Sodium API landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period 2022-2028.
The global key manufacturers of Creatine Phosphate Sodium API include Luoxin Pharmaceutical, Harbin Laiboten Pharmaceutical, Haikou Qili Pharmaceutical, Jilin Yinglian Biopharmaceutical, Hebei Tiancheng Pharmaceutical, Chongqing Shenghuaxi Pharm, Amicogen China, Kaifeng Mingren Pharmaceuticals and Beijing Polay Pharmaceuticals, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
In terms of production side, this report researches the Creatine Phosphate Sodium API capacity, production, growth rate, market share by manufacturers and by region (region level and country level), from 2017 to 2022, and forecast to 2028.
In terms of sales side, this report focuses on the sales of Creatine Phosphate Sodium API by region (region level and country level), by company, by Type and by Application. from 2017 to 2022 and forecast to 2028.
Global Creatine Phosphate Sodium API Scope and Segment
Creatine Phosphate Sodium API market is segmented by Type and by Application. Players, stakeholders, and other participants in the global Creatine Phosphate Sodium API market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on production capacity, revenue and forecast by Type and by Application for the period 2017-2028.
Segment by Type
Purity≥99%
Purity<99% Segment by Application Injection Oral Solid Preparation By Company Luoxin Pharmaceutical Harbin Laiboten Pharmaceutical Haikou Qili Pharmaceutical Jilin Yinglian Biopharmaceutical Hebei Tiancheng Pharmaceutical Chongqing Shenghuaxi Pharm Amicogen China Kaifeng Mingren Pharmaceuticals Beijing Polay Pharmaceuticals Hainan ChoiteC Pharmaceuticals Qidong Huatuo Pharmaceutical Production by Region North America Europe China Japan Consumption by Region North America United States Canada Europe Germany France U.K. Italy Russia Asia-Pacific China Japan South Korea India Australia China Taiwan Indonesia Thailand Malaysia Latin America Mexico Brazil Argentina Middle East & Africa Turkey Saudi Arabia UAE

レポート目次

1 Study Coverage
1.1 Creatine Phosphate Sodium API Product Introduction
1.2 Market by Type
1.2.1 Global Creatine Phosphate Sodium API Market Size by Type, 2017 VS 2021 VS 2028
1.2.2 Purity≥99%
1.2.3 Purity<99% 1.3 Market by Application 1.3.1 Global Creatine Phosphate Sodium API Market Size by Application, 2017 VS 2021 VS 2028 1.3.2 Injection 1.3.3 Oral Solid Preparation 1.4 Study Objectives 1.5 Years Considered 2 Global Creatine Phosphate Sodium API Production 2.1 Global Creatine Phosphate Sodium API Production Capacity (2017-2028) 2.2 Global Creatine Phosphate Sodium API Production by Region: 2017 VS 2021 VS 2028 2.3 Global Creatine Phosphate Sodium API Production by Region 2.3.1 Global Creatine Phosphate Sodium API Historic Production by Region (2017-2022) 2.3.2 Global Creatine Phosphate Sodium API Forecasted Production by Region (2023-2028) 2.4 North America 2.5 Europe 2.6 China 2.7 Japan 3 Global Creatine Phosphate Sodium API Sales in Volume & Value Estimates and Forecasts 3.1 Global Creatine Phosphate Sodium API Sales Estimates and Forecasts 2017-2028 3.2 Global Creatine Phosphate Sodium API Revenue Estimates and Forecasts 2017-2028 3.3 Global Creatine Phosphate Sodium API Revenue by Region: 2017 VS 2021 VS 2028 3.4 Global Creatine Phosphate Sodium API Sales by Region 3.4.1 Global Creatine Phosphate Sodium API Sales by Region (2017-2022) 3.4.2 Global Sales Creatine Phosphate Sodium API by Region (2023-2028) 3.5 Global Creatine Phosphate Sodium API Revenue by Region 3.5.1 Global Creatine Phosphate Sodium API Revenue by Region (2017-2022) 3.5.2 Global Creatine Phosphate Sodium API Revenue by Region (2023-2028) 3.6 North America 3.7 Europe 3.8 Asia-Pacific 3.9 Latin America 3.10 Middle East & Africa 4 Competition by Manufactures 4.1 Global Creatine Phosphate Sodium API Production Capacity by Manufacturers 4.2 Global Creatine Phosphate Sodium API Sales by Manufacturers 4.2.1 Global Creatine Phosphate Sodium API Sales by Manufacturers (2017-2022) 4.2.2 Global Creatine Phosphate Sodium API Sales Market Share by Manufacturers (2017-2022) 4.2.3 Global Top 10 and Top 5 Largest Manufacturers of Creatine Phosphate Sodium API in 2021 4.3 Global Creatine Phosphate Sodium API Revenue by Manufacturers 4.3.1 Global Creatine Phosphate Sodium API Revenue by Manufacturers (2017-2022) 4.3.2 Global Creatine Phosphate Sodium API Revenue Market Share by Manufacturers (2017-2022) 4.3.3 Global Top 10 and Top 5 Companies by Creatine Phosphate Sodium API Revenue in 2021 4.4 Global Creatine Phosphate Sodium API Sales Price by Manufacturers 4.5 Analysis of Competitive Landscape 4.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI) 4.5.2 Global Creatine Phosphate Sodium API Market Share by Company Type (Tier 1, Tier 2, and Tier 3) 4.5.3 Global Creatine Phosphate Sodium API Manufacturers Geographical Distribution 4.6 Mergers & Acquisitions, Expansion Plans 5 Market Size by Type 5.1 Global Creatine Phosphate Sodium API Sales by Type 5.1.1 Global Creatine Phosphate Sodium API Historical Sales by Type (2017-2022) 5.1.2 Global Creatine Phosphate Sodium API Forecasted Sales by Type (2023-2028) 5.1.3 Global Creatine Phosphate Sodium API Sales Market Share by Type (2017-2028) 5.2 Global Creatine Phosphate Sodium API Revenue by Type 5.2.1 Global Creatine Phosphate Sodium API Historical Revenue by Type (2017-2022) 5.2.2 Global Creatine Phosphate Sodium API Forecasted Revenue by Type (2023-2028) 5.2.3 Global Creatine Phosphate Sodium API Revenue Market Share by Type (2017-2028) 5.3 Global Creatine Phosphate Sodium API Price by Type 5.3.1 Global Creatine Phosphate Sodium API Price by Type (2017-2022) 5.3.2 Global Creatine Phosphate Sodium API Price Forecast by Type (2023-2028) 6 Market Size by Application 6.1 Global Creatine Phosphate Sodium API Sales by Application 6.1.1 Global Creatine Phosphate Sodium API Historical Sales by Application (2017-2022) 6.1.2 Global Creatine Phosphate Sodium API Forecasted Sales by Application (2023-2028) 6.1.3 Global Creatine Phosphate Sodium API Sales Market Share by Application (2017-2028) 6.2 Global Creatine Phosphate Sodium API Revenue by Application 6.2.1 Global Creatine Phosphate Sodium API Historical Revenue by Application (2017-2022) 6.2.2 Global Creatine Phosphate Sodium API Forecasted Revenue by Application (2023-2028) 6.2.3 Global Creatine Phosphate Sodium API Revenue Market Share by Application (2017-2028) 6.3 Global Creatine Phosphate Sodium API Price by Application 6.3.1 Global Creatine Phosphate Sodium API Price by Application (2017-2022) 6.3.2 Global Creatine Phosphate Sodium API Price Forecast by Application (2023-2028) 7 North America 7.1 North America Creatine Phosphate Sodium API Market Size by Type 7.1.1 North America Creatine Phosphate Sodium API Sales by Type (2017-2028) 7.1.2 North America Creatine Phosphate Sodium API Revenue by Type (2017-2028) 7.2 North America Creatine Phosphate Sodium API Market Size by Application 7.2.1 North America Creatine Phosphate Sodium API Sales by Application (2017-2028) 7.2.2 North America Creatine Phosphate Sodium API Revenue by Application (2017-2028) 7.3 North America Creatine Phosphate Sodium API Sales by Country 7.3.1 North America Creatine Phosphate Sodium API Sales by Country (2017-2028) 7.3.2 North America Creatine Phosphate Sodium API Revenue by Country (2017-2028) 7.3.3 United States 7.3.4 Canada 8 Europe 8.1 Europe Creatine Phosphate Sodium API Market Size by Type 8.1.1 Europe Creatine Phosphate Sodium API Sales by Type (2017-2028) 8.1.2 Europe Creatine Phosphate Sodium API Revenue by Type (2017-2028) 8.2 Europe Creatine Phosphate Sodium API Market Size by Application 8.2.1 Europe Creatine Phosphate Sodium API Sales by Application (2017-2028) 8.2.2 Europe Creatine Phosphate Sodium API Revenue by Application (2017-2028) 8.3 Europe Creatine Phosphate Sodium API Sales by Country 8.3.1 Europe Creatine Phosphate Sodium API Sales by Country (2017-2028) 8.3.2 Europe Creatine Phosphate Sodium API Revenue by Country (2017-2028) 8.3.3 Germany 8.3.4 France 8.3.5 U.K. 8.3.6 Italy 8.3.7 Russia 9 Asia Pacific 9.1 Asia Pacific Creatine Phosphate Sodium API Market Size by Type 9.1.1 Asia Pacific Creatine Phosphate Sodium API Sales by Type (2017-2028) 9.1.2 Asia Pacific Creatine Phosphate Sodium API Revenue by Type (2017-2028) 9.2 Asia Pacific Creatine Phosphate Sodium API Market Size by Application 9.2.1 Asia Pacific Creatine Phosphate Sodium API Sales by Application (2017-2028) 9.2.2 Asia Pacific Creatine Phosphate Sodium API Revenue by Application (2017-2028) 9.3 Asia Pacific Creatine Phosphate Sodium API Sales by Region 9.3.1 Asia Pacific Creatine Phosphate Sodium API Sales by Region (2017-2028) 9.3.2 Asia Pacific Creatine Phosphate Sodium API Revenue by Region (2017-2028) 9.3.3 China 9.3.4 Japan 9.3.5 South Korea 9.3.6 India 9.3.7 Australia 9.3.8 China Taiwan 9.3.9 Indonesia 9.3.10 Thailand 9.3.11 Malaysia 10 Latin America 10.1 Latin America Creatine Phosphate Sodium API Market Size by Type 10.1.1 Latin America Creatine Phosphate Sodium API Sales by Type (2017-2028) 10.1.2 Latin America Creatine Phosphate Sodium API Revenue by Type (2017-2028) 10.2 Latin America Creatine Phosphate Sodium API Market Size by Application 10.2.1 Latin America Creatine Phosphate Sodium API Sales by Application (2017-2028) 10.2.2 Latin America Creatine Phosphate Sodium API Revenue by Application (2017-2028) 10.3 Latin America Creatine Phosphate Sodium API Sales by Country 10.3.1 Latin America Creatine Phosphate Sodium API Sales by Country (2017-2028) 10.3.2 Latin America Creatine Phosphate Sodium API Revenue by Country (2017-2028) 10.3.3 Mexico 10.3.4 Brazil 10.3.5 Argentina 11 Middle East and Africa 11.1 Middle East and Africa Creatine Phosphate Sodium API Market Size by Type 11.1.1 Middle East and Africa Creatine Phosphate Sodium API Sales by Type (2017-2028) 11.1.2 Middle East and Africa Creatine Phosphate Sodium API Revenue by Type (2017-2028) 11.2 Middle East and Africa Creatine Phosphate Sodium API Market Size by Application 11.2.1 Middle East and Africa Creatine Phosphate Sodium API Sales by Application (2017-2028) 11.2.2 Middle East and Africa Creatine Phosphate Sodium API Revenue by Application (2017-2028) 11.3 Middle East and Africa Creatine Phosphate Sodium API Sales by Country 11.3.1 Middle East and Africa Creatine Phosphate Sodium API Sales by Country (2017-2028) 11.3.2 Middle East and Africa Creatine Phosphate Sodium API Revenue by Country (2017-2028) 11.3.3 Turkey 11.3.4 Saudi Arabia 11.3.5 UAE 12 Corporate Profiles 12.1 Luoxin Pharmaceutical 12.1.1 Luoxin Pharmaceutical Corporation Information 12.1.2 Luoxin Pharmaceutical Overview 12.1.3 Luoxin Pharmaceutical Creatine Phosphate Sodium API Sales, Price, Revenue and Gross Margin (2017-2022) 12.1.4 Luoxin Pharmaceutical Creatine Phosphate Sodium API Product Model Numbers, Pictures, Descriptions and Specifications 12.1.5 Luoxin Pharmaceutical Recent Developments 12.2 Harbin Laiboten Pharmaceutical 12.2.1 Harbin Laiboten Pharmaceutical Corporation Information 12.2.2 Harbin Laiboten Pharmaceutical Overview 12.2.3 Harbin Laiboten Pharmaceutical Creatine Phosphate Sodium API Sales, Price, Revenue and Gross Margin (2017-2022) 12.2.4 Harbin Laiboten Pharmaceutical Creatine Phosphate Sodium API Product Model Numbers, Pictures, Descriptions and Specifications 12.2.5 Harbin Laiboten Pharmaceutical Recent Developments 12.3 Haikou Qili Pharmaceutical 12.3.1 Haikou Qili Pharmaceutical Corporation Information 12.3.2 Haikou Qili Pharmaceutical Overview 12.3.3 Haikou Qili Pharmaceutical Creatine Phosphate Sodium API Sales, Price, Revenue and Gross Margin (2017-2022) 12.3.4 Haikou Qili Pharmaceutical Creatine Phosphate Sodium API Product Model Numbers, Pictures, Descriptions and Specifications 12.3.5 Haikou Qili Pharmaceutical Recent Developments 12.4 Jilin Yinglian Biopharmaceutical 12.4.1 Jilin Yinglian Biopharmaceutical Corporation Information 12.4.2 Jilin Yinglian Biopharmaceutical Overview 12.4.3 Jilin Yinglian Biopharmaceutical Creatine Phosphate Sodium API Sales, Price, Revenue and Gross Margin (2017-2022) 12.4.4 Jilin Yinglian Biopharmaceutical Creatine Phosphate Sodium API Product Model Numbers, Pictures, Descriptions and Specifications 12.4.5 Jilin Yinglian Biopharmaceutical Recent Developments 12.5 Hebei Tiancheng Pharmaceutical 12.5.1 Hebei Tiancheng Pharmaceutical Corporation Information 12.5.2 Hebei Tiancheng Pharmaceutical Overview 12.5.3 Hebei Tiancheng Pharmaceutical Creatine Phosphate Sodium API Sales, Price, Revenue and Gross Margin (2017-2022) 12.5.4 Hebei Tiancheng Pharmaceutical Creatine Phosphate Sodium API Product Model Numbers, Pictures, Descriptions and Specifications 12.5.5 Hebei Tiancheng Pharmaceutical Recent Developments 12.6 Chongqing Shenghuaxi Pharm 12.6.1 Chongqing Shenghuaxi Pharm Corporation Information 12.6.2 Chongqing Shenghuaxi Pharm Overview 12.6.3 Chongqing Shenghuaxi Pharm Creatine Phosphate Sodium API Sales, Price, Revenue and Gross Margin (2017-2022) 12.6.4 Chongqing Shenghuaxi Pharm Creatine Phosphate Sodium API Product Model Numbers, Pictures, Descriptions and Specifications 12.6.5 Chongqing Shenghuaxi Pharm Recent Developments 12.7 Amicogen China 12.7.1 Amicogen China Corporation Information 12.7.2 Amicogen China Overview 12.7.3 Amicogen China Creatine Phosphate Sodium API Sales, Price, Revenue and Gross Margin (2017-2022) 12.7.4 Amicogen China Creatine Phosphate Sodium API Product Model Numbers, Pictures, Descriptions and Specifications 12.7.5 Amicogen China Recent Developments 12.8 Kaifeng Mingren Pharmaceuticals 12.8.1 Kaifeng Mingren Pharmaceuticals Corporation Information 12.8.2 Kaifeng Mingren Pharmaceuticals Overview 12.8.3 Kaifeng Mingren Pharmaceuticals Creatine Phosphate Sodium API Sales, Price, Revenue and Gross Margin (2017-2022) 12.8.4 Kaifeng Mingren Pharmaceuticals Creatine Phosphate Sodium API Product Model Numbers, Pictures, Descriptions and Specifications 12.8.5 Kaifeng Mingren Pharmaceuticals Recent Developments 12.9 Beijing Polay Pharmaceuticals 12.9.1 Beijing Polay Pharmaceuticals Corporation Information 12.9.2 Beijing Polay Pharmaceuticals Overview 12.9.3 Beijing Polay Pharmaceuticals Creatine Phosphate Sodium API Sales, Price, Revenue and Gross Margin (2017-2022) 12.9.4 Beijing Polay Pharmaceuticals Creatine Phosphate Sodium API Product Model Numbers, Pictures, Descriptions and Specifications 12.9.5 Beijing Polay Pharmaceuticals Recent Developments 12.10 Hainan ChoiteC Pharmaceuticals 12.10.1 Hainan ChoiteC Pharmaceuticals Corporation Information 12.10.2 Hainan ChoiteC Pharmaceuticals Overview 12.10.3 Hainan ChoiteC Pharmaceuticals Creatine Phosphate Sodium API Sales, Price, Revenue and Gross Margin (2017-2022) 12.10.4 Hainan ChoiteC Pharmaceuticals Creatine Phosphate Sodium API Product Model Numbers, Pictures, Descriptions and Specifications 12.10.5 Hainan ChoiteC Pharmaceuticals Recent Developments 12.11 Qidong Huatuo Pharmaceutical 12.11.1 Qidong Huatuo Pharmaceutical Corporation Information 12.11.2 Qidong Huatuo Pharmaceutical Overview 12.11.3 Qidong Huatuo Pharmaceutical Creatine Phosphate Sodium API Sales, Price, Revenue and Gross Margin (2017-2022) 12.11.4 Qidong Huatuo Pharmaceutical Creatine Phosphate Sodium API Product Model Numbers, Pictures, Descriptions and Specifications 12.11.5 Qidong Huatuo Pharmaceutical Recent Developments 13 Industry Chain and Sales Channels Analysis 13.1 Creatine Phosphate Sodium API Industry Chain Analysis 13.2 Creatine Phosphate Sodium API Key Raw Materials 13.2.1 Key Raw Materials 13.2.2 Raw Materials Key Suppliers 13.3 Creatine Phosphate Sodium API Production Mode & Process 13.4 Creatine Phosphate Sodium API Sales and Marketing 13.4.1 Creatine Phosphate Sodium API Sales Channels 13.4.2 Creatine Phosphate Sodium API Distributors 13.5 Creatine Phosphate Sodium API Customers 14 Market Drivers, Opportunities, Challenges and Risks Factors Analysis 14.1 Creatine Phosphate Sodium API Industry Trends 14.2 Creatine Phosphate Sodium API Market Drivers 14.3 Creatine Phosphate Sodium API Market Challenges 14.4 Creatine Phosphate Sodium API Market Restraints 15 Key Finding in The Global Creatine Phosphate Sodium API Study 16 Appendix 16.1 Research Methodology 16.1.1 Methodology/Research Approach 16.1.2 Data Source 16.2 Author Details 16.3 Disclaimer